As of 2025-05-17, the Fair Value of Arcus Biosciences Inc (RCUS) is -13.36 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.56 USD, the upside of Arcus Biosciences Inc is -256.11%.
With the market price of 8.56 USD and our fair value calculation, Arcus Biosciences Inc (RCUS) is not a good investment. Investing in Arcus stocks now will result in a potential loss of 256.11%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -122.90 | 52.80 | -267.00 | -307.00 | -283.00 | -185.42 |
| YoY growth | -45.10% | 142.96% | -605.68% | -14.98% | 7.82% | -103.00% |
| Market Cap (mil) | 906.42 |
| P/E | |
| Forward P/E |
| EPS | -2.67 |
| Avg earnings growth rate | -103.00% |
| TTM earnings | -283.00 |